OrphanDrug
OrphanDrug
Pharma Knowledge Base

drug-induced methemoglobinemia

ORPHA: 464453

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Methemoglobinemia that is caused by exposure to certain drugs (xylocaine and benzene)

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with drug-induced methemoglobinemia, sourced from HPO and Orphanet clinical annotations.

MethemoglobinemiaAnxietyCyanosisConfusionAcidosisPalpitationsVomitingDyspneaHeadacheVertigoFatigueHypoxemiaComaSyncopeTachycardiaAbdominal painDrowsinessLoss of consciousnessArrhythmiaSeizureRespiratory distress

Classification & Codes

Orphanet Code

ORPHA:464453
drug-induced methemoglobinemia
OrphanetORPHA:464453
Treatments0 drug(s)
Symptoms on record21 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO